Clinical Observation of Long-term Efficacy and Safety of Glycyrrhizic Acid Preparation in the Therapy of Autoimmune Liver Disease
Condition(s):Autoimmune Liver DiseaseLast Updated:July 23, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Autoimmune Liver DiseaseLast Updated:July 23, 2019Completed
Condition(s):Chronic Liver DiseaseLast Updated:December 16, 2022Recruiting
Condition(s):Patternsof Liver Diseasesadmissions After Era of DAASLast Updated:March 17, 2022Not yet recruiting
Condition(s):Anemia; Chronic Liver DiseaseLast Updated:September 28, 2021Recruiting
Condition(s):Liver DiseasesLast Updated:January 4, 2022Completed
Condition(s):Chronic Liver DiseaseLast Updated:March 29, 2021Not yet recruiting
Condition(s):NAFLD; Obesity, Morbid; Comorbidities and Coexisting ConditionsLast Updated:September 26, 2022Recruiting
Condition(s):Chronic Liver DiseaseLast Updated:April 19, 2022Recruiting
Condition(s):Nonalcoholic Fatty Liver DiseaseLast Updated:August 10, 2022Not yet recruiting
Condition(s):Liver DiseasesLast Updated:January 28, 2011Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.